The Current Ratio as of December 2025 (TTM) for Fractyl Health, Inc. Common Stock (GUTS) is 4.27

According to Fractyl Health, Inc. Common Stock’s latest financial reports and current stock price. The company's current Current Ratio is 4.27. This represents a change of 46.86% compared to the average of 2.90 of the last 4 quarters.

Fractyl Health, Inc. Common Stock (GUTS) Historical Current Ratio (quarterly & annually)

How has GUTS Current Ratio performed in the past?

The mean historical Current Ratio of Fractyl Health, Inc. Common Stock over the last ten years is 3.79. The current 4.27 Current Ratio has changed 11.14% with respect to the historical average. Over the past ten years (40 quarters), GUTS's Current Ratio was at its highest in in the March 2024 quarter at 9.38. The Current Ratio was at its lowest in in the September 2020 quarter at 0.

Fractyl Health, Inc. Common Stock (GUTS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Fractyl Health, Inc. Common Stock Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Fractyl Health, Inc. Common Stock (GUTS) Average Current Ratio

How has GUTS Current Ratio performed in the past?

The current Current Ratio of Fractyl Health, Inc. Common Stock (GUTS) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Fractyl Health, Inc. Common Stock (GUTS) Current Ratio vs. Peers

How is GUTS’s Current Ratio compared to its peers?

Fractyl Health, Inc. Common Stock’s Current Ratio is greater than Adverum Biotechnologies, Inc. (0.65), less than ALX Oncology Holdings Inc. (4.52), greater than Precision BioSciences, Inc. (3.45), less than Artiva Biotherapeutics, Inc. (11.65), greater than Sutro Biopharma, Inc. (2.53), less than Quince Therapeutics, Inc. (5.00), less than Metagenomi, Inc. Common Stock (6.36), less than Repare Therapeutics Inc. (10.71), less than aTyr Pharma, Inc. (5.93), greater than Biomea Fusion, Inc. (3.18),

Build a custom stock screener for Fractyl Health, Inc. Common Stock (GUTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fractyl Health, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fractyl Health, Inc. Common Stock (GUTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fractyl Health, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.